Overview
Yoko Amino practices practicing medicine in Kyoto, Japan.
Ms. Amino is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Schnitzler Syndrome, Retinopathy Pigmentary Mental Retardation, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Retinitis Pigmentosa.
She is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yoko Amino
Is Yoko Amino a top-rated expert for Schnitzler Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Yoko Amino is classified as an Advanced expert for Schnitzler Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yoko Amino participate in research or clinical trials?
Yes. Yoko Amino has published 9 articles and abstracts on conditions like Schnitzler Syndrome. You can view a list of Yoko Amino's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Retinopathy Pigmentary Mental Retardation
- Schnitzler SyndromeMs. Amino isAdvanced. Learn about Schnitzler Syndrome.
- Experienced
- Late-Onset Retinal DegenerationMs. Amino isExperienced. Learn about Late-Onset Retinal Degeneration.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Retinitis PigmentosaMs. Amino isExperienced. Learn about Retinitis Pigmentosa.
- WartsMs. Amino isExperienced. Learn about Warts.